![](/img/cover-not-exists.png)
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial
Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke, Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert, Weller, Johannes, Mack, FJournal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-019-03246-4
Date:
July, 2019
File:
PDF, 926 KB
2019